ABSTRACT. Objective. Acellular pertussis vaccines were introduced with the promise of an improved safety profile compared with whole-cell vaccines. In 1997-1998, Canada adopted 1 combination acellular pertussis vaccine, having previously used 1 particular combination whole-cell pertussis vaccine. We hypothesized that the change would result in a decrease in hospitalization rates for seizures and reports of hypotonic-hyporesponsive episodes (HHEs) temporally related to pertussis vaccination.Methods. Active surveillance was performed between 1995 and 2001 by the Immunization Monitoring Program-Active monitors at 12 hospitals using standard case definitions. Seizures had to occur within 72 hours after immunization with a pertussis-containing vaccine or 5 to 30 days after immunization with measles-mumpsrubella vaccine. HHE episodes had to occur within 48 hours of receipt of a pertussis-containing vaccine. Poisson regression models were used to compare the average number of monthly admissions for seizures and HHEs before and after introduction of the acellular pertussis vaccine.Results. We found a 79% decrease in febrile seizures associated with receipt of pertussis vaccine but no significant decrease in febrile seizures temporally related to measles-mumps-rubella between 1995-1996 and 1998 -2001. There was a 60% to 67% reduction in HHEs associated with pertussis-containing vaccines between the same time periods, depending on case definition.Conclusions. The risks of febrile seizures and HHEs after pertussis-containing vaccine declined significantly with the introduction of acellular pertussis vaccine in Canada. Active surveillance systems are important for detecting trends in uncommon adverse events after routine immunizations. Pediatrics 2003;112:e348 -e353. URL: http://www.pediatrics.org/cgi/content/full/112/5/e348; childhood vaccination, acellular pertussis vaccine, febrile seizures, hypotonic-hyporesponsive episodes, active surveillance, adverse events.ABBREVIATIONS. HHE, hypotonic-hyporesponsive episode; MMR, measles-mumps-rubella; VAERS, Vaccine Adverse Events Reporting System; IMPACT, Immunization Monitoring ProgramActive. P ertussis immunization has been controversial because of concerns about neurologic complications, including seizures and hypotonic-hyporesponsive episodes (HHEs). [1][2][3][4][5][6][7][8] Although studies have noted a low risk of afebrile seizures after pertussis immunization, 9,10 a small but increased risk of febrile seizures has been observed. Relative risk has been estimated to be between 1.5 and 5 compared with unvaccinated children. 9 -16 The relative risk of febrile seizures in children 6 to 14 days after the receipt of measles-mumps-rubella (MMR) vaccine has been estimated at 2 to 3 compared with nonimmunized children. 10,14,16,17 Collapse or "shock-like" states known as HHEs have also been recognized as a rare but important adverse event usually occurring within 24 hours of receipt of whole-cell pertussis vaccine. An excellent review of the topic was recently published. 18 The re...